Differences between the European and Eurasian Good Pharmacovigilance Practices
Good pharmacovigilance practices (GVP) of the Eurasian Economic Union (EAEU) were prepared based on the GVP of the European Medicines Agency that have been in force in the European Union (EU) since 2012. The EAEU GVP have been in force in the Russian Federation and the other EAEU member states since...
Saved in:
Main Authors: | A. V. Matveev (Author), A. E. Krasheninnikov (Author), E. A. Matveeva (Author), B. K. Romanov (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
by: A. V. Matveev, et al.
Published: (2023) -
Pharmacovigilance system in Eurasian Economic Union
by: I. L. Asetskaya, et al.
Published: (2019) -
Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
by: A. E. Krasheninnikov, et al.
Published: (2021) -
Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023) -
Good Pharmacovigilance Practice in the United States and the European Union
by: V. A. Merkulov, et al.
Published: (2022)